Aquestive Therapeutics (AQST) Share-based Compensation (2018 - 2026)
Aquestive Therapeutics (AQST) reported Share-based Compensation of $2.9 million for Q2 2026, up 53.7% from $1.88 million a year earlier and up 24.9% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Share-based Compensation (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Aquestive Therapeutics' Share-based Compensation came in at $9.37 million, up 25.7% year-over-year; for FY2025, it was $7.62 million, up 7.4% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 3.0% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $7.1 million in FY2024 (+164.0%), $2.69 million in FY2023 (-38.6%), $4.38 million in FY2022 (-35.8%) and $6.82 million in FY2021 (+3.6%).
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation since Q2 2018.
- Year over year, Share-based Compensation gained in seven of the last eight quarters, with growth averaging 51.9%.
- The high point for year-over-year Share-based Compensation in five years was Q1 2024 (growth of 359.3%); the low point was Q3 2022 (a decline of 71.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.32 million (Q1 2026), $1.38 million (Q4 2025) and $2.78 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Aquestive Therapeutics | 581.12 Mn | 121.66 Mn | 9.80 Mn | 2.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.90 Mn |
| Mar 31, 2026 | 2.32 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | 2.78 Mn |
| Jun 30, 2025 | 1.88 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 2.40 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 1.54 Mn |
| Mar 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | 940,000.00 |
| Sep 30, 2023 | 774,000.00 |
| Jun 30, 2023 | 631,000.00 |
| Mar 31, 2023 | 344,000.00 |
| Dec 31, 2022 | 714,000.00 |
| Sep 30, 2022 | 535,000.00 |
| Jun 30, 2022 | 2.22 Mn |
| Mar 31, 2022 | 913,000.00 |
| Dec 31, 2021 | 1.69 Mn |
| Sep 30, 2021 | 1.90 Mn |
API Access
Aquestive Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();